Hims Stock Faces 15% Earnings Swing as Weight-Loss Pivot Comes Due
Hims & Hers Health shares jumped 9.3% to $28.03 Friday as options traders bet on a 14.8% swing after next week’s earnings. The company will report first-quarter results after markets close May 11. Analysts remain divided, with price targets ranging from $25 to $32. Hims recently launched a compounded testosterone pill and an AI lab-results tool, and expanded access to FDA-approved weight-loss drugs.